These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 7808021)

  • 21. Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group.
    Paredes J; Kahn JO; Tong WP; Feldstein ML; Lin S; Bennett JM; Metroka CE; Ratner L; Krown SE
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):138-44. PubMed ID: 7749790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study.
    Dezube BJ; Krown SE; Lee JY; Bauer KS; Aboulafia DM
    J Clin Oncol; 2006 Mar; 24(9):1389-94. PubMed ID: 16549833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Weekly docetaxel is safe and effective in the treatment of advanced-stage acquired immunodeficiency syndrome-related Kaposi sarcoma.
    Lim ST; Tupule A; Espina BM; Levine AM
    Cancer; 2005 Jan; 103(2):417-21. PubMed ID: 15578686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma.
    Bihl F; Berger C; Chisholm JV; Henry LM; Bertisch B; Trojan A; Nadal D; Speck RF; Flepp M; Brander C; Mueller NJ;
    AIDS; 2009 Sep; 23(14):1918-22. PubMed ID: 19609199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of low-dose interferon with antiretroviral therapy in Kaposi's sarcoma: a randomized phase II AIDS clinical trials group study.
    Krown SE; Li P; Von Roenn JH; Paredes J; Huang J; Testa MA
    J Interferon Cytokine Res; 2002 Mar; 22(3):295-303. PubMed ID: 12034036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma.
    Gill PS; McLaughlin T; Espina BM; Tulpule A; Louie S; Lunardi-Iskandar Y; Gallo RC
    J Natl Cancer Inst; 1997 Dec; 89(23):1797-802. PubMed ID: 9392621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
    Gill PS
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):53-7. PubMed ID: 1719642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary Kaposi's sarcoma in AIDS patients treated with combined chemotherapy and recombinant human granulocyte colony-stimulating factor.
    Mastroianni A; Coronado O; Cancellieri C; Manfredi R; Pignatari S; Chiodo F
    J Chemother; 1998 Oct; 10(5):405-10. PubMed ID: 9822360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I/II study of intermittent all-trans-retinoic acid, alone and in combination with interferon alfa-2a, in patients with epidemic Kaposi's sarcoma.
    Bailey J; Pluda JM; Foli A; Saville MW; Bauza S; Adamson PC; Murphy RF; Cohen RB; Broder S; Yarchoan R
    J Clin Oncol; 1995 Aug; 13(8):1966-74. PubMed ID: 7636537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous infusion etoposide in advanced AIDS-related kaposi sarcoma.
    Remick SC; Reddy M; Ekman K; Vyzula R; Hilstro J; Horton J
    J Infus Chemother; 1996; 6(2):92-6. PubMed ID: 8809657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS.
    Krown SE; Paredes J; Bundow D; Polsky B; Gold JW; Flomenberg N
    J Clin Oncol; 1992 Aug; 10(8):1344-51. PubMed ID: 1634925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi's sarcoma.
    Aboulafia D; Miles SA; Saks SR; Mitsuyasu RT
    J Acquir Immune Defic Syndr (1988); 1989; 2(1):54-8. PubMed ID: 2918461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase II study of recombinant human interferon-alpha 2a and zidovudine in patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group.
    Fischl MA; Finkelstein DM; He W; Powderly WG; Triozzi PL; Steigbigel RT
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(4):379-84. PubMed ID: 8601224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".
    Volkow P; Zinser JW; Correa-Rotter R
    BMC Nephrol; 2007 Mar; 8():6. PubMed ID: 17386117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma.
    Gill PS; Tulpule A; Espina BM; Cabriales S; Bresnahan J; Ilaw M; Louie S; Gustafson NF; Brown MA; Orcutt C; Winograd B; Scadden DT
    J Clin Oncol; 1999 Jun; 17(6):1876-83. PubMed ID: 10561228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma.
    Tulpule A; Scadden DT; Espina BM; Cabriales S; Howard W; Shea K; Gill PS
    J Clin Oncol; 2000 Feb; 18(4):716-23. PubMed ID: 10673512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of antitumor activity and intolerance of interleukin-4 in patients with advanced HIV disease and Kaposi's sarcoma.
    Miles SA; Testa M; Huang J; Wade M; Carden J; Scadden DT
    J Interferon Cytokine Res; 2002 Nov; 22(11):1143-8. PubMed ID: 12513914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma.
    Gill PS; Bernstein-Singer M; Espina BM; Rarick M; Magy F; Montgomery T; Berry MS; Levine A
    AIDS; 1992 Dec; 6(12):1477-81. PubMed ID: 1283520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intralesional bevacizumab in patients with human immunodeficiency virus-associated Kaposi's sarcoma in the upper airway.
    Ablanedo-Terrazas Y; Alvarado-de la Barrera C; Ormsby CE; Ruiz-Cruz M; Reyes-Terán G
    Laryngoscope; 2015 Apr; 125(4):E132-7. PubMed ID: 25345840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.